Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | UGT2B7 | P16662 | 1/20 | 0.46 |
| ▸ | MEN1 | O00255 | 1/20 | 0.43 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.43 |
| ▸ | ESR1 | P03372 | 1/20 | 0.43 |
| ▸ | ESR2 | Q92731 | 1/20 | 0.43 |
| ▸ | NOS3 | P29474 | 1/20 | 0.43 |
| ▸ | NOS1 | P29475 | 1/20 | 0.43 |
| ▸ | SRD5A2 | P31213 | 1/20 | 0.42 |
| ▸ | LTA4H | P09960 | 1/20 | 0.41 |
| ▸ | MAPT | P10636 | 1/20 | 0.41 |
| ▸ | HPGD | P15428 | 1/20 | 0.41 |
| ▸ | RAB9A | P51151 | 1/20 | 0.41 |
| ▸ | ACACB | O00763 | 4/20 | 0.41 |
| ▸ | ACACA | Q13085 | 4/20 | 0.41 |
| ▸ | SCN9A | Q15858 | 1/20 | 0.40 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.39 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.38 |
| ▸ | TSHR | P16473 | 1/20 | 0.38 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.38 |
| ▸ | NPY5R | Q15761 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL18383080 | 0.91 | LTA4H (0.56) | MEN1KMT2ALTA4HRAB9AALDH1A1 | |
| SCHEMBL9923547 | 0.91 | TEAD4 (0.50) | UGT2B7MEN1KMT2ANOS3NOS1 | |
| SCHEMBL4368301 | 0.91 | SRD5A2 (0.55) | UGT2B7SRD5A2LTA4HHPGDACACB | |
| SCHEMBL14222884 | 0.91 | ESR1 (0.61) | UGT2B7MEN1KMT2AESR1ESR2 | |
| Hydrochloric Acid SCHEMBL8692147 | 0.89 | SRD5A2 (0.53) | UGT2B7SRD5A2LTA4HHPGDACACB | |
| SCHEMBL7608525 | 0.85 | ALDH1A1 (0.42) | UGT2B7MEN1KMT2ANOS3NOS1 | |
| SCHEMBL18383082 | 0.85 | LTA4H (0.50) | MEN1KMT2ALTA4HRAB9AALDH1A1 | |
| SCHEMBL18383076 | 0.85 | LTA4H (0.50) | MEN1KMT2ASRD5A2LTA4HRAB9A | |
| SCHEMBL22174155 | 0.85 | TEAD4 (0.45) | MEN1KMT2AMAPTACACBACACA | |
| SCHEMBL18383081 | 0.85 | LTA4H (0.50) | ESR2LTA4HRAB9AACACBACACA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250368595-A1 | NOVEL MOLECULES | Xeniopro GmbH (DE) | 2025-12-04 | — | — | US | claimed |
| US-20080003377-A1 | Transparent vacuum system | THE BOARD OF REGENTS OF THE NEVADA SYSTEM OF HIGHER ED. ON BEHALF OF THE UNLV | 2008-01-03 | — | — | US | claimed |
| US-20250368595-A1 | NOVEL MOLECULES | Xeniopro GmbH (DE) | 2025-12-04 | — | — | US | disclosed |
| US-20230141913-A2 | PHENOXY(HETERO)ARYL ETHERS OF ANTIPROLIFERACTIVE ACTIVITY | Xeniopro GmbH (DE) | 2023-05-11 | — | — | US | disclosed |
| US-20220249500-A1 | PHENOXY(HETERO)ARYL ETHERS OF ANTIPROLIFERACTIVE ACTIVITY | Xeniopro GmbH (DE) | 2022-08-11 | — | — | US | disclosed |
| US-20080003377-A1 | Transparent vacuum system | THE BOARD OF REGENTS OF THE NEVADA SYSTEM OF HIGHER ED. ON BEHALF OF THE UNLV | 2008-01-03 | — | — | US | disclosed |
| US-20020007029-A1 | Novel polyester resins | ZAITSEY BORIS A (RU) | 2002-01-17 | — | — | US | disclosed |
| EP-1129116-A1 | NOVEL POLYMERIZABLE MATERIALS AND NOVEL POLYESTER RESINS | Zaitsev, Boris A. (RU) | 2001-09-05 | — | — | EP | disclosed |
| US-6258909-B1 | Polyester resins | ZAITSEV BORIS A (RU) | 2001-07-10 | — | — | US | disclosed |
| US-6143922-A | NOVEL DIOL COMPOSITIONS, NOVEL UNSATURATED MONOMERS, NOVEL RESINS, NOVEL CROSSLINKED POLYMERS, NOVEL POLYESTER POLYMERS, NOVEL POLYESTER POLYMERS THAT DISPLAY IMPROVEMENT OVER ROLIVSAN RESINS | ZAITSEV BORIS A (RU) | 2000-11-07 | — | — | US | disclosed |
| WO-2000023485-A1 | NOVEL POLYMERIZABLE MATERIALS AND NOVEL POLYESTER RESINS | ZAITSEV BORIS A (RU) | 2000-04-27 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20220249500-A1 | PHENOXY(HETERO)ARYL ETHERS OF ANTIPROLIFERACTIVE ACTIVITY | AHR, MUSK, TYR | UGT2B7 185/4885MEN1 4794/4885KMT2A 762/4885 |
| US-20250368595-A1 | NOVEL MOLECULES | MUSK, IKZF3, TYR | UGT2B7 1940/4885MEN1 4589/4885KMT2A 957/4885 |
| US-20230141913-A2 | PHENOXY(HETERO)ARYL ETHERS OF ANTIPROLIFERACTIVE ACTIVITY | AHR, MUSK, TYR | UGT2B7 185/4885MEN1 4794/4885KMT2A 762/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.